Sanofi· @sanofi · X·· 28 天前精选AI 评分58
AI 导读
赛诺菲在UEG Week公布其在研疗法治疗溃疡性结肠炎和克罗恩病的2b期长期阳性数据,并与Teva共同参与#UEGWeek2026。原文未披露具体药物名称、疗效数字与随访时长,更多内容见赛诺菲新闻稿链接。
推荐理由
赛诺菲公布溃疡性结肠炎与克罗恩病2b期长期数据,读者可据此了解该在研疗法在两项适应症上的持续表现。
正文
#NEWS: Positive phase 2b long-term data in ulcerative colitis and Crohn's disease, shared at UEG Week. Read more: https://www.sanofi.com/en/media-room/press-releases/2026/2026-10-20-12-00-00-3384293
@Teva #UEGWeek2026
来源:Sanofi · x.com